CRSP is trading 4.3% down at $59.22 today as the stock pulls back from its recent rally amid mixed broader market action.
- The move appears to be normal volatility for the high-beta biotech name following strong gains in early July.
- There are no fresh company-specific headlines or major events driving the decline today.
- Broader market sentiment remains cautious, contributing to the downward pressure on riskier assets.